Who has invested in 89bio?

OrbiMed Israel, OrbiMed US, Longitude Capital, RA Capital Management, Pontifax are named among the investors backing 89bio.

89bio Funding: $60M Raised, Series A (2018)

89bio funding overview

89bio is based in San Francisco, California. 89bio has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2018. The round record for 89bio runs through 2018; nothing later has been disclosed. Investors on record include OrbiMed Israel, OrbiMed US, Longitude Capital, RA Capital Management, Pontifax. 5 distinct backers are named across the disclosed rounds.

89bio at a glance

Total raised: $60M
Latest round: Series A
Latest round date: October 2018
Headquarters: San Francisco, California
Notable investors: OrbiMed Israel, OrbiMed US, Longitude Capital, RA Capital Management, Pontifax

Frequently asked about 89bio funding

How much has 89bio raised?: 89bio has raised $60M in total disclosed funding across the rounds on record.
Who has invested in 89bio?: OrbiMed Israel, OrbiMed US, Longitude Capital, RA Capital Management, Pontifax are named among the investors backing 89bio.
What was the latest 89bio funding round?: The most recent disclosed round is a Series A, announced in October 2018.
Where is 89bio based?: 89bio is based in San Francisco, California.
When did 89bio last raise?: The last disclosed 89bio round closed in October 2018 at Series A.

89bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Francisco below to benchmark round size and investor mix.

89bio Funding: $60M Raised, Series A (2018)

89bio funding overview

89bio at a glance

Frequently asked about 89bio funding

Companies related to 89bio (18)

Browse related funding lists (8)